Literature DB >> 23870422

Radiation sensitivity and sensitization in melanoma.

David Shahbazian1, Ranjit S Bindra, Harriet M Kluger, Peter M Glazer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23870422      PMCID： PMC3866027          DOI： 10.1111/pcmr.12147

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  12 in total

Review 1.  Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma.

Authors:  Graham Stevens; Michael J McKay
Journal:  Lancet Oncol       Date:  2006-07       Impact factor: 41.316

2.  Some factors of importance in the radiation treatment of malignant melanoma.

Authors:  J Overgaard; M Overgaard; P V Hansen; H von der Maase
Journal:  Radiother Oncol       Date:  1986-03       Impact factor: 6.280

3.  In vitro evaluation of temozolomide combined with X-irradiation.

Authors:  S R Wedge; J K Porteous; M G Glaser; K Marcus; E S Newlands
Journal:  Anticancer Drugs       Date:  1997-01       Impact factor: 2.248

Review 4.  Radiotherapy for malignant melanoma: a re-appraisal.

Authors:  A R Harwood; B J Cummings
Journal:  Cancer Treat Rev       Date:  1981-12       Impact factor: 12.111

5.  Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

Authors:  B Fertil; E P Malaise
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-05       Impact factor: 7.038

6.  PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Authors:  Ruth Halaban; Wengeng Zhang; Antonella Bacchiocchi; Elaine Cheng; Fabio Parisi; Stephan Ariyan; Michael Krauthammer; James P McCusker; Yuval Kluger; Mario Sznol
Journal:  Pigment Cell Melanoma Res       Date:  2010-02-10       Impact factor: 4.693

7.  Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.

Authors:  Brett L Carlson; Patrick T Grogan; Ann C Mladek; Mark A Schroeder; Gaspar J Kitange; Paul A Decker; Caterina Giannini; Wenting Wu; Karla A Ballman; C David James; Jann N Sarkaria
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-01       Impact factor: 7.038

8.  Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study.

Authors:  H J M Groen; A H W van der Leest; E Fokkema; P R Timmer; G D Nossent; W J G M Smit; J Nabers; H J Hoekstra; J Hermans; R Otter; J W G van Putten; E G E de Vries; N H Mulder
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

9.  Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation.

Authors:  L X Yang; E B Douple; J A O'Hara; H J Wang
Journal:  Radiat Res       Date:  1995-09       Impact factor: 2.841

10.  In vitro studies of Taxol as a radiation sensitizer in human tumor cells.

Authors:  J Liebmann; J A Cook; J Fisher; D Teague; J B Mitchell
Journal:  J Natl Cancer Inst       Date:  1994-03-16       Impact factor: 13.506
View more
  6 in total

1.  PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF.

Authors:  Parker L Sulkowski; Susan E Scanlon; Sebastian Oeck; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2018-05-08       Impact factor: 5.852

2.  Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.

Authors:  Julian Scheper; Laura S Hildebrand; Eva-Maria Faulhaber; Lisa Deloch; Udo S Gaipl; Julia Symank; Rainer Fietkau; Luitpold V Distel; Markus Hecht; Tina Jost
Journal:  Strahlenther Onkol       Date:  2022-10-13       Impact factor: 4.033

3.  Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery.

Authors:  Charles E Rutter; Kimberly L Johung; Xiaopan Yao; Alex Y Lu; Lucia B Jilaveanu; James B Yu; Joseph N Contessa; Harriet M Kluger; Veronica L S Chiang; Ranjit S Bindra
Journal:  J Radiosurg SBRT       Date:  2016

4.  Identification of novel radiosensitizers in a high-throughput, cell-based screen for DSB repair inhibitors.

Authors:  Alexander G Goglia; Robert Delsite; Antonio N Luz; David Shahbazian; Ahmed F Salem; Ranjini K Sundaram; Jeanne Chiaravalli; Petrus J Hendrikx; Jennifer A Wilshire; Maria Jasin; Harriet M Kluger; J Fraser Glickman; Simon N Powell; Ranjit S Bindra
Journal:  Mol Cancer Ther       Date:  2014-12-15       Impact factor: 6.009

5.  Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cells.

Authors:  Audrey Turchick; Yanfeng Liu; Weixi Zhao; Inessa Cohen; Peter M Glazer
Journal:  Oncotarget       Date:  2019-02-12

6.  Flow cytometric assessment of DNA double-strand break and repair kinetics in prediction of intrinsic radiosensitivity.

Authors:  Mohammad-Taghi Bahreyni-Toossi; Mahdieh Dayyani; Mahmoud Mahmoudi; Hosein Azimian
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.